Demand for Americas Hospital Acquired Infection Testing Market to Attain a Valuation of US$ 2.7 Bn by 2031 end

As per Fact.MR – a market research and competitive intelligence provider, the Americas hospital acquired infection testing market was valued at US$ 595 Mn in 2020, and is expected to exhibit a CAGR of around 15% over the forecast period (2021-2031).

Infants, elderly people, and people with weak immunity systems are at a greater risk of developing hospital acquired infections (HAIs). Many common antibiotics are resistant to various organisms present in hospitals. Widespread use of antibiotics in hospitals promotes the development of resistant bacteria. Urinary tract infection (UTI), surgical site infections, pneumonia, lung infections, and bacterial infections are commonly acquired hospital infections.

For detailed insights on enhancing your product footprint, request for a sample here –

As per the Centers of Disease Control and Prevention (CDC) estimates, in hospitals across the Americas alone, 1.7 million patients suffer from HAIs and 99,000 deaths occur every. This high mortality rate associated economic burden has compelled healthcare providers to device an effective strategy to lower infection rates.

The current COVID-19 pandemic crisis is expected to have a moderately positive impact on market growth. This can be attributed to growing number hospitalizations due to COVID-19 across the Americas. Prolonged hospital stays and frequent use of ventilators increase the chances of patients acquiring infections. Thus, as the number of hospitalizations is high, demand for HAI testing kits is expected to see a rise.

Key Takeaways from Market Study

  • By test, helicobacter pylori testing kits hold around 26.4% value share of the total Americas market.
  • Based on modality, point-of-care testing is leading with 69% market share.

For critical insights on this market, request for methodology here –

  • By end user, diagnostic laboratories dominate the HAI testing market with a value share of 35%, while on the other hand, home care settings are expected to increase at a higher CAGR of 23%.
  • By country, the U.S. dominates the Americas hospital acquired infection testing market with a value share of 58%.

americas hospital acquired infection testing-market competition by FactMR

Segments as per Americas Hospital Acquired Infection Testing Industry Research


  • Immunoassay Testing
  • Point-of-care Testing

By Sample

  • Blood
  • Nasal Swabs
  • Urine
  • Stool

For in-depth competitive analysis, buy now –

Who is winning?

The Americas market is set to expand due to rise in incidence of hospital acquired infections. Leading industry players are set to focus on research & development as well as strategic & geographic expansion in order to strengthen their presence in the region.

Some of the leading players in the market include, but not limited to, Altona Diagnostics, bioMérieux SA, Abbott, ThermoFisher Scientific, Danaher Corporation, ELI Tech Group, Becton Dickinson, Hoffmann-La Roche Ltd, Qiagen, Pro-lab diagnostics, Liofilchem, savyonDiagnostics, and CTK Biotech.

Read More Trending and Similar Reports from Fact.MR –

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Hand Hygiene Monitoring System Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028-

Dental Amalgamators Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028-

Actigraphy Sensors Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028-

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: